(Updates numbers, adds details, quotes)
TORONTO, Feb 1 (Reuters) - The Toronto Stock Exchange’s main index climbed broadly higher on Friday, helped by robust energy and banking shares, solid earnings, and optimism over Microsoft’s takeover bid for Yahoo.
The energy and financials sectors led the way, gaining 1.5 percent and 1.6 percent respectively as investors sensed bargains after the market’s recent slump.
The banking sector was also boosted as investors continued digest the U.S. interest rate cut earlier in the week and were hopeful of another cut from the Bank of Canada.
Bank of Montreal BMO.TO gained C$1.32, or 2.3 percent, to C$58.07, while in the energy sector, Encana Corp ECA.TO was up C$1.33, or 2 percent, at C$67.52.
“The financials definitely had the brunt of selloff when the market was down to almost 12,000 last month, so certainly some buying is coming back into those groups,” said Elvis Picardo, investment strategist at Northern Securities Inc. in Vancouver, British Columbia.
The S&P/TSX composite index .GSPTSE closed up 163.27 points, or 1.24 percent, at 13,318.37 with eight of its 10 main groups finishing higher.
TransAlta Corp TA.TO gained 62 Canadian cents, or 1.9 percent, to C$32.52 after it returned to profit in the fourth quarter and said it is looking at selling its Mexican power plants.
Sierra Wireless Inc SW.TO SWIR.O was up C$1.27, or 8.6 percent, at C$16.12 after reporting a fourth-quarter profit after markets closed on Thursday that beat forecasts.
Celestica Inc CLS.TO CLS.N also released its earnings after the bell on Thursday. The contract electronics manufacturer reported a smaller quarterly loss and higher-than-expected revenue, sending its shares up 76 Canadian cents, or 13 percent, to C$6.61.
The tech sector gained 1.5 percent on news of an unsolicited takeover offer for Yahoo Inc YHOO.O from Microsoft Corp (MSFT.O).
On the downside, Biovail Corp BVF.TO BVF.N lost 46 Canadian cents, or 3.4 percent, to C$13.25 after it said it is being investigated by a U.S. federal grand jury in connection with the 2003 launch of its Cardizem LA heart drug.
$1=$0.99 Canadian Reporting by Leah Schnurr; Editing by Peter Galloway